Pyridam Farma Tbk PT
IDX:PYFA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nedap NV
LSE:0NNU
|
NL |
|
Zhejiang Mustang Battery Co Ltd
SSE:605378
|
CN |
|
F
|
Farmae SpA
MIL:FAR
|
IT |
|
A
|
ANI Joint Stocks Co
VN:SIC
|
VN |
|
C
|
Cochlear Ltd
OTC:CHEOF
|
AU |
|
C
|
Catalyst Bancorp Inc
NASDAQ:CLST
|
US |
|
A
|
Akfen Yenilenebilir Enerji AS
IST:AKFYE.E
|
TR |
|
Panex Resources Inc
OTC:DBGF
|
MC |
|
P
|
Paninvest Tbk PT
XBER:OA9
|
ID |
|
B
|
B2Gold Corp
AMEX:BTG
|
CA |
|
P
|
Provident Financial Holdings Inc
NASDAQ:PROV
|
US |
Pyridam Farma Tbk PT
Total Equity
Pyridam Farma Tbk PT
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Total Equity
Rp732.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
39%
|
CAGR 10-Years
22%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Total Equity
Rp9.4T
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Total Equity
Rp23.3T
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Total Equity
Rp1.5T
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Total Equity
Rp2.7T
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Total Equity
Rp2.9T
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
4%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Total Equity?
Total Equity
732.9B
IDR
Based on the financial report for Sep 30, 2025, Pyridam Farma Tbk PT's Total Equity amounts to 732.9B IDR.
What is Pyridam Farma Tbk PT's Total Equity growth rate?
Total Equity CAGR 10Y
22%
Over the last year, the Total Equity growth was -39%. The average annual Total Equity growth rates for Pyridam Farma Tbk PT have been 17% over the past three years , 39% over the past five years , and 22% over the past ten years .
